๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Veratrum Alkaloids XXXV

โœ Scribed by Morris Kupchan, S. ;Gruenfeld, Norbert


Book ID
102412625
Publisher
Elsevier
Year
1959
Weight
403 KB
Volume
48
Category
Article
ISSN
0095-9553

No coin nor oath required. For personal study only.

โœฆ Synopsis


Cryptenamine has been reported to have a more favorable ratio of emetic to h potensive dose than other veratrum preparations, and the advantageous ratio has geen attributed to the presence of new hypotensive alkaloids. Cryptenamine was fractionated with the aid of partition column chromatography, adsorption column chromatography, and paper partition chromatography. The known hypotensive alkaloids protoveratrine A, protoveratrine B, germitrine, neogermitrine, germerine, and germidine were isolated. I n addition, the relatively nonhypotensive alkaloids jervine, rubijervine, isorubijervine, and an apparently new noncarbonyl alkamine were obtained. Paper chromatographic evidence suggesting the presence of the hypotensive alkaloids germbudine and neogermbudine and the relatively nonhypotensive veratramine was also obtained.

URE veratrum alkaloids and their prepara-Ptions have been administered in recent years for the treatment of hypertension. T h e deterrent to the wider use of these agents in therapy is the narrow range between their therapeutic and emetic doses (1).

Cryptenamine, a n alkaloidal preparation obtained from Veratrum wiride by a nonaqueous benzene-triethylamine extraction procedure has been reported t o have a ratio of emetic t o effective hypotensive dose superior to t h a t of other veratrum preparations (2-5). In humans, the divergence between the hypotensive and the emetic doses was most apparent on intravenous administration (5). The satisfactory ambulatory treatment of arterial hypertension by oral administration of cryptenamine has also been reported (6). However, Abreu, et al. (7), reported in 1954 that cryptenamine did not demonstrate a ratio of emetic t o hypotensive dose superior to t h a t of protoveratrine A when tested in dogs. The advantageous pharmacological properties of cryptenamine have been attributed to the presence of new amorphous hypotensive ester alkaloids reportedly lost b y hydrolysis during the alternative aqueous ammonia-benzene extraction procedure (2-4). It was the purpose of this investigation t o identify t h e components of cryptenamine which are responsible for its hypotensive activity.

EXPERIMENTAL

Melting points are conected for stem exposure. Values of [ e ] D have been approximated to the near-*


๐Ÿ“œ SIMILAR VOLUMES


Veratrum Alkaloids XXXVII
โœ Morris Kupchan, S. ;Afonso, Adriano ๐Ÿ“‚ Article ๐Ÿ“… 1959 ๐Ÿ› Elsevier โš– 367 KB
Veratrum Alkaloids XL
โœ Morris Kupchan, S. ;Ian Ayres, C. ๐Ÿ“‚ Article ๐Ÿ“… 1959 ๐Ÿ› Elsevier โš– 179 KB
Veratrum Alkaloids XLI
โœ Morris Kupchan, S. ;Gruenfeld, Norbert ๐Ÿ“‚ Article ๐Ÿ“… 1959 ๐Ÿ› Elsevier โš– 288 KB
Alkaloids of Veratrum lobelianum
โœ K. A. Abaidullaev; R. Shakirov; S. Yu. Yunusov ๐Ÿ“‚ Article ๐Ÿ“… 1974 ๐Ÿ› Springer ๐ŸŒ English โš– 70 KB
Alkaloids of Veratrum lobelianum
โœ R. Shakirov; S. Yu. Yunusov ๐Ÿ“‚ Article ๐Ÿ“… 1971 ๐Ÿ› Springer ๐ŸŒ English โš– 119 KB
Alkaloids from Veratrum album
โœ Atta-ur-Rahman; Rahat Azhar Ali; Tahira Parveen; M.Iqbal Choudhary; Bilge Sener; ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 321 KB